Dr Tannir on Unmet Needs in the Treatment of Rare Kidney Tumors
Nizar M. Tannir, MD, FACP, discusses unmet needs for patients with rare kidney tumors and how these needs may be addressed in the future.
Nizar M. Tannir, MD, FACP, discusses unmet needs for patients with rare kidney tumors and how these needs may be addressed in the future.
Decades of research has dramatically changed cancer care, with more breakthrough treatments on the way thanks to clinical trials that pair patients with oncology experts.
Sattva S. Neelapu, MD, discusses the optimal processes of CAR T-cell therapy administration and the remaining unmet needs in the space.
Thoracic anesthesia is a specialized procedure that allows one lung to continue breathing under anesthesia while the other lung is operated on. Stephanie Bradley, M.D.,…
As immunotherapy makes its way into the perioperative setting, a growing number of clinical trials are expanding the evidence base for resectable non-small cell lung…
Abstract. First-generation KRAS G12C inhibitors, such as sotorasib and adagrasib, are limited by the depth and duration of clinical responses. One potential explanation for their…
Jameel Muzaffar, MD, discusses findings from the phase 2 portion of the FLX475-02 study examining tivumecirnon plus pembrolizumab in HNSCC.
The healthcare sector’s necessary transition towards electronic health records (EHRs) has transformed patient care and operational efficiency. To access this subscriber-only content please log in…
An abstract is unavailable.
9MW2821 was granted an orphan drug designation from the FDA and is being evaluated for the potential treatment of esophageal cancer, as well as other…